AI Stock Picks — S&P 500

Thursday, October 29, 2026  ·  Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days

Today's Market Mood

Neutral  Normal choppiness · VIX 16.9

The market is in a sharp rotation: mega-cap tech and high-multiple growth names (META, GOOGL, NFLX, AVGO, MRVL, NVDA) are selling off hard on disappointing guidance, while energy, healthcare/medtech, industrials, insurance, and select financials are grinding to new 52-week highs on steady multi-week momentum. Breadth outside tech looks constructive, so selective long exposure in the leaders of this rotation looks more attractive than chasing the beaten-down growth names.

Rotation out of mega-cap/AI-adjacent tech into value, energy, and defensive-growth sectorsBroad-based strength in energy majors and E&Ps trading near 52-week highs on firm crude/gas pricingSteady breakout momentum in healthcare equipment, diagnostics, and life-science instrument namesIndustrials, insurance, and payments/exchange names showing persistent 30-day uptrends near highs

Today's Actionable List

Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.

0 of 5
0%
88 · 148.2%
148.2% / 60%
0 of 20
RankStockActionSizeEntry → TargetNotes
#1 DGX SKIP — $251.88 → $265.22
stop $233.24
Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#2 ACGL SKIP — $103.99 → $109.31
stop $97.75
Position cap reached — 88 of 20 slots in use.
#3 EMR SKIP — $169.94 → $178.44
stop $159.91
Position cap reached — 88 of 20 slots in use.
#4 BLK SKIP — $1,169.62 → $1,232.08
stop $1,097.10
Position cap reached — 88 of 20 slots in use.
#5 TMO SKIP — $705.75 → $742.20
stop $652.82
Half-Kelly sizes this at 0% — the odds carry no edge worth capital.

Already open: ALW.L (to Nov 1), MSFT (to Nov 4), AMZN (to Nov 8), PYPL (to Nov 8), HUM (to Nov 11), TJX (to Nov 11), BNZL.L (to Nov 12), LIN (to Nov 13), GILD (to Nov 14), UNH (to Nov 14), WMT (to Nov 14), CTEC.L (to Nov 14) … and 76 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.

Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.

Behind the scenes: how each AI analyst did
Aria
8 picks
Blaze
7 picks
Nova
4 picks
Orion
6 picks
Quinn
7 picks

5 Stock Picks

#1 DGXQuest Diagnostics Incorporated
5/5 Agents Agree  Risk 5/10  ⚠ Conflicting Signals
Moderate conviction · 56%

Quest Diagnostics runs medical testing labs across the country. Its stock has quietly outperformed the market over the past month with healthy, sustainable momentum, and because it already reported earnings last week, there's no earnings surprise risk left in the next 30 days. The main risk is a broader healthcare-sector pullback or a reimbursement/regulatory headline.

Stop-loss$233.24-7.4%
Today's price$251.88
Target$265.22+5.3%
Agents estimate: $265.98 (+0.3% vs target)
If you invested $1,000
▲$1,053 if the target hits (+5.3%)
▼$926 if the stop-loss is hit (-7.4%)
The AI puts the chance of the win case at 56%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Price is already pinned at the top of its Bollinger Band ($251.88 vs. upper band $249.25) and only 0.10% from its 52-week high, leaving very little technical room to run before a mean-reversion pullback.
  • On-balance volume is actually negative (-135,400) despite the 8.6% price surge, meaning the rally has not been confirmed by accumulating volume — a red flag for sustainability even without a formal divergence tag.
Show the detailed analysis

Calibrated probability: 56% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.

Trade math

0.7:1
58%
+1.1%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
76%
Very High
Nova
58%
Medium
Orion
66%
High
Quinn
60%
Medium
#2 ACGLArch Capital Group Ltd.
4/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals
Moderate conviction · 56%

Arch Capital is a global insurance and reinsurance company. After beating earnings expectations a few days ago, its shares are trending higher with healthy momentum and no overbought warning signs, fitting the market's current rotation into insurance and financial names. The main risk is an unexpected large claims event, like a natural disaster, that wouldn't show up in the price chart ahead of time.

Stop-loss$97.75-6.0%
Today's price$103.99
Target$109.31+5.1%
Agents estimate: $109.44 (+0.1% vs target)
If you invested $1,000
▲$1,051 if the target hits (+5.1%)
▼$940 if the stop-loss is hit (-6.0%)
The AI puts the chance of the win case at 56%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • The stock is already trading above its own upper Bollinger Band ($103.99 vs. $105.23 is close, but note price sits just 2.9% off its 52-week high with 5-day momentum decelerating sharply to just 0.96% after a 9.3% monthly run — the move is losing steam, not accelerating.
Show the detailed analysis

Calibrated probability: 56% (raw model estimate: 66%) — adjusted using the accuracy of past resolved picks.

Trade math

0.9:1
54%
+1.3%
8.5%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
63%
High
Nova
—
—
The company beat earnings estimates by a wide margin a few days ago, but the share price barely moved in response, a warning sign the market isn't rewarding the beat.
Orion
66%
High
Quinn
60%
Medium
#3 EMREmerson Electric Co.
3/5 Agents Agree  Risk 4/10  ⚠ Earnings in Window
Strong conviction · 60%

Emerson Electric makes industrial automation and process-control equipment used in factories and energy plants. Its stock is climbing steadily with healthy (not overheated) momentum, a bullish technical crossover, and a tightening price range that often precedes a breakout — all while industrials lead the current market rotation. The main risk is that a broad market pullback or cautious comments at its upcoming earnings call could stall the rally.

Stop-loss$159.91-5.9%
Today's price$169.94
Target$178.44+5.0%
If you invested $1,000
▲$1,050 if the target hits (+5.0%)
▼$941 if the stop-loss is hit (-5.9%)
The AI puts the chance of the win case at 60%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • The Bollinger squeeze (true) is being framed as bullish, but squeezes are directionally neutral — they precede a breakout in either direction, and with RSI already at 69.3 and price just 0.76% from its 52-week high, a downside resolution is equally plausible.
  • 5-day momentum (2.65%) has roughly halved versus the 30-day pace of 8.1%/period, suggesting the trend is already decelerating ahead of any squeeze resolution.
Show the detailed analysis

Calibrated probability: 60% (raw model estimate: 72%) — adjusted using the accuracy of past resolved picks.

Trade math

0.8:1
54%
+1.9%
8.5%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
80%
Very High
Blaze
—
—
Emerson's only available recent filing is an accounting restatement rather than a results release, leaving no clear fresh catalyst and only a weak technical case.
Nova
—
—
Orion
65%
High
Quinn
70%
High
#4 BLKBlackRock, Inc.
3/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals
Moderate conviction · 56%

BlackRock is the world's largest asset manager, running investment funds including the popular iShares ETFs. Its shares have climbed steadily and are beating the market, supported by healthy technical readings, fitting the market's current preference for financial names. The main risk is that a market-wide downturn would reduce the value of the assets it manages, hurting its fees and the stock.

Stop-loss$1,097.10-6.2%
Today's price$1,169.62
Target$1,232.08+5.3%
Agents estimate: $1,236.07 (+0.3% vs target)
If you invested $1,000
▲$1,053 if the target hits (+5.3%)
▼$938 if the stop-loss is hit (-6.2%)
The AI puts the chance of the win case at 56%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • Despite a 9.6% 30-day rally, the 5-day momentum figure is only 0.62%, indicating the move has almost completely stalled over the last week even as price sits just 0.7% below the upper Bollinger Band ($1,169.62 vs. $1,176.99) and 1.48% off the 52-week high — little room left before resistance.
Show the detailed analysis

Calibrated probability: 56% (raw model estimate: 69%) — adjusted using the accuracy of past resolved picks.

Trade math

0.9:1
54%
+1.8%
8.5%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
71%
Very High
Nova
—
—
No company-specific catalyst was found, and the next earnings report is nearly three months away, leaving no near-term trigger.
Orion
—
—
Asset managers aren't the specific financial names singled out in the current rotation story, and short-term momentum has stalled.
Quinn
60%
Medium
#5 TMOThermo Fisher Scientific Inc.
3/5 Agents Agree  Risk 5/10
Moderate conviction · 56%

Thermo Fisher Scientific supplies lab instruments and equipment used across the pharmaceutical and research industries. Its uptrend is more modest than some peers but is backed by healthy, not-overbought momentum, and its most recent earnings report is already behind it, removing near-term earnings risk from this pick's window. The main risk is that demand for its equipment is tied to biotech/pharma research budgets, which can soften if funding tightens.

Stop-loss$652.82-7.5%
Today's price$705.75
Target$742.20+5.2%
Agents estimate: $743.36 (+0.2% vs target)
If you invested $1,000
▲$1,052 if the target hits (+5.2%)
▼$925 if the stop-loss is hit (-7.5%)
The AI puts the chance of the win case at 56%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • The weakest momentum of the group: 30-day return is only 3.85% (vs. peers' 8-9%), and price is already pressing the upper Bollinger Band ($705.75 vs. $710.07) just 0.86% off the 52-week high, leaving a thin margin for a further 5% move within the window.
Show the detailed analysis

Calibrated probability: 56% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.

Trade math

0.7:1
59%
+0.7%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
72%
Very High
Blaze
63%
High
Nova
—
—
Earnings beat expectations over a week ago, but the stock has only inched up about 1% since, suggesting the catalyst is already priced in with fading momentum.
Orion
60%
High
Quinn
—
—
Qualifies on trend signals but has weaker recent momentum and a less favorable downside-to-target ratio than the stronger candidates.

Retail Investor Execution Guide

This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by November 28, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.

Step-by-Step Action Plan

  1. Act within one trading day. Prices are freshest now. The longer you wait, the more the entry price drifts away from what the agents analysed.
  2. Verify the entry price. Check the live price before buying. If a stock has already moved more than 3% above the Current Price shown in the report, skip it or wait for a pullback — the risk/reward has shifted.
  3. Use limit orders, not market orders. Set your buy limit at or below the Current Price shown. Chasing with a market order gives brokers and algorithms an advantage over you.
  4. Set your stop-loss immediately after buying. Use the Max Downside % on each pick card as your hard exit level. If the price falls to that level, sell without hesitation — the trade thesis is broken.
  5. Set a take-profit at the Target Price. Place a limit sell order at the Target Price shown. When it fills, the trade is done — resist the urge to hold for more.
  6. Exit all positions by November 28, 2026. This is your hard deadline. If a stock has not hit its target by then, exit anyway. Holding past the window turns a short-term trade into an unsupervised long-term position.
  7. Never add to a losing position. If your stop-loss is hit, exit completely. Averaging down turns a small, controlled loss into a potentially large one.

Position Sizing by Conviction Tier

Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.

Agents Agreeing What It Means Max Allocation Per Pick
5/5 Highest conviction — all five independent analytical checks passed Up to 10%
4/5 Very high conviction — four of five independent checks aligned Up to 8%
3/5 High conviction — three agents independently agreed Up to 6%
2/5 Moderate conviction — two agents independently agreed Up to 4%
1 Agent Speculative — solo pick, admitted only at Very High confidence Up to 2%

The Three Exit Rules

These picks are generated by AI agents for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Probability estimates reflect the agents' analytical models — they are not guarantees of any outcome. Past results are not indicative of future performance. Markets can and do move against even well-researched trades. Always conduct your own research, and consider seeking advice from a licensed financial adviser before placing any orders. Never invest money you cannot afford to lose.

Understanding the Numbers

A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.

AI Conviction Meter
Estimated probability of hitting the target, shown as a 5-bar gauge
The filled bars and label translate the AI's probability estimate into plain language: 75%+ is Very strong, 60–74% Strong, 50–59% Moderate, below 50% Cautious. Where enough past picks have been resolved, the probability is calibrated against the AI's real track record.
e.g. "Moderate conviction · 58%" — the AI thinks this trade works slightly more often than a coin flip.
✓ More filled bars = more confidence — but even Very strong picks fail sometimes; always size positions accordingly.
If You Invested $1,000
$1,000 × (1 + Target Gain ÷ 100)  /  $1,000 × (1 + Max Downside ÷ 100)
The same Target Gain and Max Downside percentages expressed in concrete money terms for a $1,000 position — what you'd have if the target hits versus if your stop-loss is triggered.
e.g. +10% target and −12.3% stop → $1,100 on a win, $877 on a stopped-out loss.
✓ Scales linearly — a $500 position sees half these amounts, a $2,000 position double.
Current Price
Market price at time of analysis
The stock's price when this report was generated. All other figures on the card are calculated from this reference point.
e.g. $215.20 — check the live price before placing an order; if it has moved more than ~3%, re-evaluate the risk/reward.
✓ No positive/negative distinction — it is simply your cost basis.
Target Price
Current Price × (1 + Target Gain ÷ 100)
The price the agents project the stock could reach within the time window. This is your take-profit level — place a limit sell order here after buying.
e.g. $215.20 × 1.085 = $233.49 target on an 8.5% pick.
✓ Always above Current Price — this tool only selects upside candidates.
Target Gain
(Target Price − Current Price) ÷ Current Price × 100
The percentage return you would earn if the stock hits its Target Price from your entry. Set by the run parameters — every pick in this report targets the same percentage.
e.g. +8.5% means a $100 stock has a $108.50 target; a $500 stock has a $542.50 target.
✓ Always positive — picks are upside-only. A larger % means a bigger move is required.
Max Downside
Estimated stop-loss level, as % below entry
The worst-case loss the agents estimated if the thesis fails — based on key support levels and recent volatility. Use this as your hard stop-loss. If the price falls to this level, exit immediately; the trade thesis is broken.
e.g. −12.0% means: if you bought at $100, sell if it drops to $88.00.
⚠ Always negative. A smaller magnitude (e.g. −5%) = tighter risk. A larger magnitude (e.g. −20%) = more room to fall before you exit — riskier.
Reward : Risk
Target Gain ÷ |Max Downside|
How much you could gain for every dollar you are risking. A ratio of 2.0:1 means you stand to make $2 for every $1 at risk. Higher is better.
e.g. 8.5% gain ÷ 12% downside = 0.7:1 (unfavourable). 10% gain ÷ 5% downside = 2.0:1 (good).
✓ ≥ 2.0:1 is strong. ⚠ < 1.0:1 means you are risking more than you could gain — approach with caution.
Breakeven Win Rate
|Max Downside| ÷ (Target Gain + |Max Downside|) × 100
The minimum percentage of trades at this reward:risk that must succeed for you to break even over time — regardless of how good your stock picking is.
e.g. 12 ÷ (8.5 + 12) = 59% — you need roughly 6 in 10 trades to win just to avoid losing money.
✓ Lower is better — ≤ 35% means even a poor win rate is survivable. ⚠ ≥ 55% means you need most trades to work out.
Expected Value
(Probability% × Target Gain%) + ((1 − Probability%) × Max Downside%)
The average return per trade if the AI's probability estimate is accurate over many similar trades. A positive Expected Value means the trade has a mathematical edge; a negative value means the math works against you on average, even if you sometimes win.
e.g. 65% × +8.5% + 35% × −12% = +1.3% EV. Over 100 similar trades you would expect an average gain of 1.3% per trade.
✓ Positive = edge in your favour over many trades. ⚠ Negative = the math loses money on average — even if individual wins feel good. Note: EV is only as reliable as the probability estimate.
Suggested Allocation
half-Kelly: (Probability ÷ |Max Downside| − (1 − Probability) ÷ Target Gain) ÷ 2, capped at 10%
The Kelly criterion computes the portfolio fraction that maximises long-run growth for a bet with these odds; half-Kelly is the standard hedge against the probability estimate being too optimistic. Uses the calibrated probability where available. 0% means the math sees no edge worth sizing; — means it couldn't be computed.
e.g. 57% probability, +10% target, −13% downside → Kelly ≈ 8.5% of portfolio, half-Kelly ≈ 4.2%.
Generic sizing guidance only — not personal investment advice. Position sizing must reflect your own portfolio, risk tolerance and circumstances.
Every stock Scout considered — and why each was discarded

Scout scanned 503 S&P 500 constituents and short-listed 27 candidates for deep analysis by the five analysts. Here is what happened to each one.

  • SWKStanley Black & Decker, Inc.Dropped at merge
    Scout: Sharp 5-day and 30-day gains with price just 1.4% off its 52-week high, signaling a durable breakout rather than a one-day spike.
    Qualified on merit but ranked #9, outside the 5-pick limit for this run.
  • LLYEli Lilly and CompanyDropped at merge
    Scout: Consistent 5-day and 30-day gains, trading within 3% of its 52-week high — pharma leadership intact.
    Only Blaze selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: Very High, 78% raw (60% after calibration)).
  • AMGNAmgen Inc.Dropped at merge
    Scout: Steady positive momentum across both windows and just 1.8% from its 52-week high.
    Qualified on merit but ranked #7, outside the 5-pick limit for this run.
  • MSIMotorola Solutions, Inc.Already held
    Scout: 10% 30-day gain with price essentially at its 52-week high, confirming a sustained uptrend.
    Already held: a position opened 2026-10-26 runs until 2026-11-25 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • TMOThermo Fisher Scientific Inc.Picked #5
    Scout: Positive momentum in both windows, trading less than 1% off its 52-week high.
    Made the final report at #5.
  • NDAQNasdaq, Inc.Already held
    Scout: 14% 30-day gain with price near its 52-week high, reflecting strength in exchange/data franchises.
    Already held: a position opened 2026-10-26 runs until 2026-11-25 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • DGXQuest Diagnostics IncorporatedPicked #1
    Scout: Steady 5-day and 30-day gains with price essentially at its 52-week high.
    Made the final report at #1.
  • MAMastercard IncorporatedDropped at merge
    Scout: Nearly 13% 30-day gain while sitting less than 1% from its 52-week high — payments leadership holding up well.
    Only Blaze selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: High, 63% raw (56% after calibration)).
  • EWEdwards Lifesciences CorporationDropped at merge
    Scout: Strong 5-day acceleration on top of a positive 30-day trend, just 1.6% from its 52-week high.
    Qualified on merit but ranked #8, outside the 5-pick limit for this run.
  • ALLEAllegion plcAlready held
    Scout: 20% 30-day gain with price within 0.5% of its 52-week high, among the strongest breakouts in industrials.
    Already held: a position opened 2026-10-26 runs until 2026-11-25 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • EOGEOG Resources, Inc.Already held
    Scout: 15% 30-day gain with price near its 52-week high as energy names extend their uptrend.
    Already held: a position opened 2026-10-21 runs until 2026-11-20 (22 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • XOMExxonMobil Holdings CorporationAlready held
    Scout: 13% 30-day gain and just over 1% from its 52-week high, confirming broad energy-sector strength.
    Already held: a position opened 2026-10-16 runs until 2026-11-15 (17 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CVXChevron CorporationAlready held
    Scout: Consistent gains across both windows with price near its 52-week high.
    Already held: a position opened 2026-10-20 runs until 2026-11-19 (21 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • COPConocoPhillipsAlready held
    Scout: Nearly 20% 30-day gain with price within 2% of its 52-week high — one of the strongest energy momentum names.
    Already held: a position opened 2026-10-28 runs until 2026-11-27 (29 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • URIUnited Rentals, Inc.Already held
    Scout: Strong 5-day and 30-day gains with price essentially at its 52-week high.
    Already held: a position opened 2026-10-27 runs until 2026-11-26 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • LHLabcorp Holdings Inc.Dropped at merge
    Scout: Double-digit 5-day and 30-day gains, trading within 2% of its 52-week high.
    Only Nova selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: High, 65% raw (56% after calibration)).
  • CRLCharles River Laboratories International, Inc.Passed over
    Scout: 27% 30-day gain with price near its 52-week high, signaling a strong breakout in life-sciences services.
    Aria: The most extended name considered (+27% in 30 days, RSI 80.5) with the highest risk score, so reversal risk outweighs the modest edge
    Blaze: Charles River's rally rests on a stale, mixed quarter (organic growth was barely positive), and the stock is extremely overbought with heavy recent insider selling and earnings due within a week.
    Nova: No specific catalyst was found, and the stock is extremely overbought after a 27% one-month surge, raising the risk of a pullback rather than further gains.
    Orion: A 27% one-month run plus RSI above 80 and an earnings report still ahead makes the risk of a sharp give-back too high for a fresh entry.
    Quinn: RSI is deeply overbought (81) after a 27% one-month surge, raising the risk of a near-term pullback despite the strong trend.
  • NUENucor CorporationDropped at merge
    Scout: 16% 30-day gain with price near its 52-week high as steel names show renewed strength.
    Qualified on merit but ranked #6, outside the 5-pick limit for this run.
  • MTDMettler-Toledo International Inc.Liquidity filter
    Scout: Steady gains in both windows with price essentially at its 52-week high.
    20-day average daily volume 194,188 shares is below the 500,000-share liquidity floor.
  • WATWaters CorporationDropped at merge
    Scout: Positive momentum across both windows with price near its 52-week high.
    Average probability across the 2 agent(s) that selected it was 59% raw (48% after calibration), below the 52% minimum to qualify.
  • EMREmerson Electric Co.Picked #3
    Scout: Solid 5-day and 30-day gains with price just under 1% from its 52-week high.
    Made the final report at #3.
  • BLKBlackRock, Inc.Picked #4
    Scout: Steady 30-day uptrend with price near its 52-week high, reflecting asset-manager strength.
    Made the final report at #4.
  • ABBVAbbVie Inc.Already held
    Scout: Consistent gains across both windows with price just over 1% from its 52-week high.
    Already held: a position opened 2026-10-23 runs until 2026-11-22 (24 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • GILDGilead Sciences, Inc.Already held
    Scout: Positive momentum in both windows with price essentially at its 52-week high.
    Already held: a position opened 2026-10-15 runs until 2026-11-14 (16 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ADIAnalog Devices, Inc.Already held
    Scout: Strong 5-day rebound on top of a positive 30-day trend, trading within 3.5% of its 52-week high — a relative-strength semis name amid broader chip weakness.
    Already held: a position opened 2026-10-27 runs until 2026-11-26 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ACGLArch Capital Group Ltd.Picked #2
    Scout: Steady gains in both windows with price near its 52-week high, part of broad insurance-sector strength.
    Made the final report at #2.
  • BBYBest Buy Co., Inc.Dropped at merge
    Scout: Strong 30-day gain with price within 1% of its 52-week high heading into the holiday retail season.
    Only Aria selected this stock — single-agent picks require Very High confidence and at least 70% probability (this pick: Very High, 75% raw (60% after calibration)).

Agent Analytical Approaches

Aria

Momentum & Technical

Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.

Blaze

Fundamental & Earnings

Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).

Nova

News Catalyst & Event-Driven

Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.

Orion

Macro & Sector Rotation

Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.

Sage

Devil's Advocate

Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.

Quinn

Quantitative / Statistical

Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.